Article Text

Download PDFPDF
VEGF121 is downregulated most in idiopathic dilated cardiomyopathy

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Patients with idiopathic dilated cardiomyopathy (IDC) may benefit from future treatment to boost vascular endothelial growth factor (VEGF)121 and thereby development of capillaries in the myocardium. A molecular study has shown for the first time that, of all three isomers of VEGF, VEGF121 is downregulated the most in …

View Full Text